A research team from the College of Science – University of Anbar, represented by "Prof.Dr. Safaa Abdul Latif Al-Muaini", Assist. Prof.Dr. Ali Hazem Abdul Karim, and Assist. Lecturer Mohammed Mukhlis Ahmed, in collaboration with the "College of Dentistry – University of Anbar, represented by Assist. Prof.Dr. Ilham Hazem Abdul Karim", announced the "global registration of the genome of an extensively drug-resistant (XDR) clinical isolate", *Acinetobacter baumannii* strain "muks92", in the "NCBI database" under the researchers’ names.

The isolate was registered within a "whole-genome sequencing (WGS) project" (Accession: "PRJNA1246638"). It was isolated from "human blood of a patient with bacteremia in Al-Anbar, Iraq". Genomic analysis revealed a "highly complex genome" harboring "virulence genes, biofilm formation determinants, and mobile genetic elements", which collectively explain its **extensive drug-resistance (XDR) profile** and high clinical risk.

This work was published as an "Original Research Article" in the prestigious journal "Frontiers in Microbiology" (DOI: "10.3389/fmicb.2025.1680686"), a Q1 journal with strong scientometric indicators (CiteScore 9.2, Impact Factor 4.5).
Full article available at:

 https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2025.1680686/full

The study highlights the critical importance of adopting "whole-genome sequencing (WGS)", implementing "antimicrobial stewardship programs", and supporting "multi-target alternative therapeutic strategies based on genomic insights" to confront the escalating global challenge of "antimicrobial resistance".